AR
Aluri Rao Srinivasa
About Aluri Rao Srinivasa
Data last updated:
Aluri Rao Srinivasa is a Director at Rainbow Children's Medicare Limited (since 2019), Director at Janaadhar (India) Private Limited (since 2016) and Director at Qunu Labs Private Limited (since 2017), and holds 6 more current directorships. The companies operate in Healthcare, Real Estate and Construction and Information Technology. The 5 current companies with reported revenue have a combined latest revenue of ₹1,668 Cr; the largest is Rainbow Children's Medicare Limited at ₹1,567 Cr (FY 2025). Earlier, Aluri Rao Srinivasa was a Partner at Dolat Absolute Return Llp (2021–2023) and Nominee Director at Malladi Drugs And Pharmaceuticals Limited (2005–2008) and 18 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Rainbow Children's Medicare Limited L85110TG1998PLC029914 | Director | 15 Mar 2019 | 1998 | ₹1,567 Cr (FY 2025) | Active |
 Janaadhar (India) Private Limited U45201KA2007PTC044522 | Director | 23 Sep 2016 | ₹53.26 Cr (FY 2025) | Active | |
 Qunu Labs Private Limited U72900KA2016PTC096629 | Director | 13 Jun 2017 | 2016 | ₹40.53 Cr (FY 2025) | Active |
 Medisys Edutech Private Limited U72200TG2000PTC035398 | Director | 30 Nov 2017 | 2000 | ₹4.13 Cr (FY 2023) | Active |
 Ocugen India Private Limited U21001TS2023FTC173688 | Director | 02 Jun 2023 | 2023 | ₹3.68 Cr (FY 2025) | Active |
| Healthspan X Private Limited U86100TS2026PTC217760 | Director | 17 Jun 2026 | 2026 | Active | |
| Aluris Quantum Llp ACQ-5056 | Designated Partner | 12 Aug 2025 | 2025 | Active | |
| Prana Xenotransplants Private Limited U86909TS2025PTC198656 | Director | 16 May 2025 | 2025 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Dolat Absolute Return Llp AAT-4668 | Partner | 29 Jan 2021 | 2020 | ₹37.07 Cr (FY 2025) | Active |
 Malladi Drugs And Pharmaceuticals Limited U24230TN1980PLC008382 | Nominee Director | 24 Jun 2005 | 1980 | ₹627 Cr (FY 2025) | Active |
 Nextgen In-Vitro Diagnostics Private Limited U33110DL2015PTC279481 | Director | 20 Jun 2017 | 2015 | ₹1.87 Cr (FY 2024) | Active |
 Arch Pharmalabs Limited U24231MH1993PLC150891 | Nominee Director | 28 Mar 2005 | 1993 | ₹1,344 Cr (FY 2023) | Under Cirp |
| I-Ven Pharma Capital Limited U24231KA2005PLC035853 | Director | 18 Mar 2005 | 2005 | Under Liquidation | |
 Jiva Sciences Private Limited U73200KA2015PTC081318 | Director | 13 Jun 2017 | 2015 | ₹12.51 Cr (FY 2025) | Active |
| I-Ven Medi-Care India Private Limited U85110KA2007PTC043424 | Director | 20 Jul 2007 | 2007 | ₹16.2 Lakh (FY 2025) | Active |
 Tropical Animal Genetics Private Limited U74900TG2014PTC135449 | Director | 20 Jun 2017 | 2014 | ₹15.55 Cr (FY 2025) | Active |
 Morgan Stanley India Services Private Limited U74140MH2007PTC176193 | Director | 29 Sep 2009 | 2007 | Amalgamated | |
| Gallusgen Private Limited U74999TG2017PTC117965 | Director | 27 Jun 2017 | 2017 | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Aluri Rao Srinivasa
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Aluri Rao Srinivasa
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aluri Rao Srinivasa
Aluri Rao Srinivasa currently holds 9 directorships: Rainbow Children's Medicare Limited (Director, since 15 Mar 2019, revenue ₹1,567 Cr (FY 2025)); Janaadhar (India) Private Limited (Director, since 23 Sep 2016, revenue ₹53.26 Cr (FY 2025)); Qunu Labs Private Limited (Director, since 13 Jun 2017, revenue ₹40.53 Cr (FY 2025)); Medisys Edutech Private Limited (Director, since 30 Nov 2017, revenue ₹4.13 Cr (FY 2023)); Ocugen India Private Limited (Director, since 02 Jun 2023, revenue ₹3.68 Cr (FY 2025)); and 4 more.
Aluri Rao Srinivasa was first appointed on 16 Dec 2003 as Director at I-Ven Biotech Limited. The most recent appointment on record is 17 Jun 2026 at Healthspan X Private Limited.
The 5 current companies of Aluri Rao Srinivasa that report revenue have a combined latest revenue of ₹1,668 Cr: Rainbow Children's Medicare Limited ₹1,567 Cr (FY 2025); Janaadhar (India) Private Limited ₹53.26 Cr (FY 2025); Qunu Labs Private Limited ₹40.53 Cr (FY 2025); Medisys Edutech Private Limited ₹4.13 Cr (FY 2023); Ocugen India Private Limited ₹3.68 Cr (FY 2025).
Aluri Rao Srinivasa held 20 earlier board appointments: Dolat Absolute Return Llp (Partner, 29 Jan 2021 to 29 Dec 2023); Malladi Drugs And Pharmaceuticals Limited (Nominee Director, 24 Jun 2005 to 07 Apr 2008); Nextgen In-Vitro Diagnostics Private Limited (Director, 20 Jun 2017 to 05 Jun 2018); Arch Pharmalabs Limited (Nominee Director, 28 Mar 2005 to 08 Apr 2008); I-Ven Pharma Capital Limited (Director, 18 Mar 2005 to 07 Apr 2008); and 15 more.
The current boards of Aluri Rao Srinivasa's companies include Abrarali Dalal (Rainbow Children's Medicare Limited), Adarsh Kancharla (Rainbow Children's Medicare Limited), Anil Dhawan (Rainbow Children's Medicare Limited), Chirla Padmarao Dinesh Kumar (Rainbow Children's Medicare Limited), Ramesh Kancharla (Rainbow Children's Medicare Limited), Santanu Mukherjee (Rainbow Children's Medicare Limited), among others.